Investigators in Italy report that CA may be underdiagnosed in women due to sex differences in left ventricular wall thickness. Current diagnostic criteria may not accurately reflect disease severity ...
A new expert consensus decision pathway published by the American College of Cardiology highlights the importance of recognizing and diagnosing cardiac amyloidosis at an early stage to allow the most ...
"These forms of cardiac amyloidosis are rare but increasingly recognized. For the first time, patients with both forms of amyloidosis have undergone deep phenotyping using cardiac biomarkers, 12-lead ...
Cardiac amyloidosis is underrecognized in patients with heart failure; however, recent improvements in the understanding of this disease have led to developments in diagnosis and treatment. Cardiac ...
124 I-evuzamitide has received Breakthrough Therapy Designation from the Food and Drug Administration (FDA) for PET imaging in patients with suspected or known cardiac amyloidosis. 124 I-evuzamitide ...
Amyloidosis is a group of rare disorders caused by deposition of misfolded proteins as insoluble fibrils, which leads to progressive multiorgan failure and death. 1 The past 30 years have seen ...
BURLINGAME, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative products to improve the lives of patients with systemic ...
NAPLES, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative products to improve the lives of patients with systemic amyloidosis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback